Exciting CNS Breakthroughs: Where the Promise Lies
November 2, 2018
In a recent PharmaVoice article “Brain Wave: Breakthroughs Bring New Hope to CNS”, Dr. Rick Scheyer, Vice-President, Medical Affairs at Medpace, provides comment on the state of neurodegenerative diseases and related clinical trials.
Medpace to Present New Biomarker Assay Validation Methods at AAPS PharmSci 360
October 8, 2018
This year at AAPS PharmSci 360, scientists from Medpace’s bioanalytical laboratory will be presenting two scientific posters regarding new methods for biomarker assay validation. Stop by Booth #605 at the conference for more information.
Important Cookie Information – This message will only appear once.